Cross Cancer Institute - Clinical Trials Unit

Edmonton, Alberta T6G 1Z2

0 studies enrolling now · 1 studies all time

What they study most

Small Cell Lung Cancer

Studies at this site

• Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer — Completed